chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Epistaxis, Fatigue, Heart rate, Heart rate increased, Palpitations
Clinical narrative: Nose bleed, palpitations, extreme fatigue, post-exertional malaise,  brain fog, rash, depression, hair loss, sleep disturbances, leg tingling, bruises
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Presyncope, SARS-CoV-2 test
Clinical narrative: Nose bleed, palpitations, extreme fatigue, post-exertional malaise,  brain fog, rash, depression, hair loss, sleep disturbances, leg tingling, bruises
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alopecia, Blood creatine phosphokinase, Blood magnesium, Blood phosphorus, Blood thyroid stimulating hormone
Clinical narrative: Nose bleed, palpitations, extreme fatigue, post-exertional malaise,  brain fog, rash, depression, hair loss, sleep disturbances, leg tingling, bruises
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein, Chest X-ray, Contusion, Cytokine test, Dehydroepiandrosterone test
Clinical narrative: Nose bleed, palpitations, extreme fatigue, post-exertional malaise,  brain fog, rash, depression, hair loss, sleep disturbances, leg tingling, bruises
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Depression, Differential white blood cell count, Electrocardiogram, Electrocardiogram ambulatory, Epistaxis
Clinical narrative: Nose bleed, palpitations, extreme fatigue, post-exertional malaise,  brain fog, rash, depression, hair loss, sleep disturbances, leg tingling, bruises
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Epstein-Barr virus antibody, Fatigue, Feeling abnormal, Fibrin D dimer, Full blood count
Clinical narrative: Nose bleed, palpitations, extreme fatigue, post-exertional malaise,  brain fog, rash, depression, hair loss, sleep disturbances, leg tingling, bruises
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Galectin-3 test, HIV test, Insulin-like growth factor, Laboratory test, Malaise
Clinical narrative: Nose bleed, palpitations, extreme fatigue, post-exertional malaise,  brain fog, rash, depression, hair loss, sleep disturbances, leg tingling, bruises
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test, Palpitations, Paraesthesia, Prothrombin time, Rash
Clinical narrative: Nose bleed, palpitations, extreme fatigue, post-exertional malaise,  brain fog, rash, depression, hair loss, sleep disturbances, leg tingling, bruises
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sleep disorder, Thyroxine, Treponema test, Troponin I, Ultrasound pelvis
Clinical narrative: Nose bleed, palpitations, extreme fatigue, post-exertional malaise,  brain fog, rash, depression, hair loss, sleep disturbances, leg tingling, bruises
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urine analysis
Clinical narrative: Nose bleed, palpitations, extreme fatigue, post-exertional malaise,  brain fog, rash, depression, hair loss, sleep disturbances, leg tingling, bruises
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immediate post-injection reaction, Loss of consciousness, Pallor
Clinical narrative: became very ridge, appeared to lose consciousness, but eyes were open and arms were turned up and clinched to chest.  Was about 1-2 mins after receiving vaccine.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Loss of consciousness, Muscle rigidity
Clinical narrative: became very ridge, appeared to lose consciousness, but eyes were open and arms were turned up and clinched to chest.  Was about 1-2 mins after receiving vaccine.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Hypoaesthesia
Clinical narrative: Hip and joint pain; Pain in arm; Hard to walk; Pain in arm moved a little to the left arm; hard to sleep; This is a spontaneous report from a contactable consumer (patient). A 71-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 2 via an unspecified route of administration, administered in right arm on 11Apr2021 at 15:15 (at the age of 71-year-old) (Batch/Lot Number: ER8730) as dose 2, single for covid-19 immunisation. Medical history included ongoing sleep apnoea, ongoing hypothyroidism, ongoing Hashimoto's disease, osteopenia, ongoing dry eye, ongoing depression, ongoing weight adjustment, ongoing selenium all from an unspecified date where patient states that need selenium and don't get enough in food. And also ongoing herpes from an unspecified date in 1982. Patient previously took first dose of BNT162B2 (at the age of 71-year-old) (lot number: EN6203, vaccine location: Right arm) on 21Mar2021 for covid-19 immunisation and experienced a little tired on the same day and was also recovered on the same day. Consumer reported that she did not have any side effects until 3 days after she received the second dose of the Covid-19 vaccine. Consumer did not provide details for past medications. On 14Apr2021, the patient experienced hip and joint pain, pain in arm and also mentioned that she felt hard to walk. It was also reported that the patient also experienced hard to sleep and mentioned pain in arm moved a little to the left arm on an unspecified date. Where the patient received treatment hard to sleep. The therapeutic measures were pain medicine before she goes to bed. It was reported that no additional vaccines administered. Patient did not visited emergency room and physician office regarding the event. Patient had no adverse events prior to vaccination. It was also mentioned that there was no family medical history relevant to events. Patient did not receive any other vaccines within 4 weeks to the COVID vaccine. The patient underwent lab tests and procedures which included anion gap resulted 2.7 (unspecified units), blood chloride resulted 108 (unspecified units), blood thyroid stimulating hormone resulted low, bone densitometry resulted osteoporosis went down, full blood count resulted normal, lipids resulted 81 (unspecified units), mammogram resulted normal, thyroxin binding globulin resulted 1.0 (unspecified units), thyroxine: 0.87 (unspecified units) and ultrasound breast and normal all on 08Apr2021. Outcome of hard to sleep was unknown. Outcome of all the other events was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anion gap, Arthralgia, Blood chloride, Blood thyroid stimulating hormone, Bone densitometry
Clinical narrative: Hip and joint pain; Pain in arm; Hard to walk; Pain in arm moved a little to the left arm; hard to sleep; This is a spontaneous report from a contactable consumer (patient). A 71-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 2 via an unspecified route of administration, administered in right arm on 11Apr2021 at 15:15 (at the age of 71-year-old) (Batch/Lot Number: ER8730) as dose 2, single for covid-19 immunisation. Medical history included ongoing sleep apnoea, ongoing hypothyroidism, ongoing Hashimoto's disease, osteopenia, ongoing dry eye, ongoing depression, ongoing weight adjustment, ongoing selenium all from an unspecified date where patient states that need selenium and don't get enough in food. And also ongoing herpes from an unspecified date in 1982. Patient previously took first dose of BNT162B2 (at the age of 71-year-old) (lot number: EN6203, vaccine location: Right arm) on 21Mar2021 for covid-19 immunisation and experienced a little tired on the same day and was also recovered on the same day. Consumer reported that she did not have any side effects until 3 days after she received the second dose of the Covid-19 vaccine. Consumer did not provide details for past medications. On 14Apr2021, the patient experienced hip and joint pain, pain in arm and also mentioned that she felt hard to walk. It was also reported that the patient also experienced hard to sleep and mentioned pain in arm moved a little to the left arm on an unspecified date. Where the patient received treatment hard to sleep. The therapeutic measures were pain medicine before she goes to bed. It was reported that no additional vaccines administered. Patient did not visited emergency room and physician office regarding the event. Patient had no adverse events prior to vaccination. It was also mentioned that there was no family medical history relevant to events. Patient did not receive any other vaccines within 4 weeks to the COVID vaccine. The patient underwent lab tests and procedures which included anion gap resulted 2.7 (unspecified units), blood chloride resulted 108 (unspecified units), blood thyroid stimulating hormone resulted low, bone densitometry resulted osteoporosis went down, full blood count resulted normal, lipids resulted 81 (unspecified units), mammogram resulted normal, thyroxin binding globulin resulted 1.0 (unspecified units), thyroxine: 0.87 (unspecified units) and ultrasound breast and normal all on 08Apr2021. Outcome of hard to sleep was unknown. Outcome of all the other events was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Full blood count, Gait disturbance, Insomnia, Lipids, Mammogram
Clinical narrative: Hip and joint pain; Pain in arm; Hard to walk; Pain in arm moved a little to the left arm; hard to sleep; This is a spontaneous report from a contactable consumer (patient). A 71-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 2 via an unspecified route of administration, administered in right arm on 11Apr2021 at 15:15 (at the age of 71-year-old) (Batch/Lot Number: ER8730) as dose 2, single for covid-19 immunisation. Medical history included ongoing sleep apnoea, ongoing hypothyroidism, ongoing Hashimoto's disease, osteopenia, ongoing dry eye, ongoing depression, ongoing weight adjustment, ongoing selenium all from an unspecified date where patient states that need selenium and don't get enough in food. And also ongoing herpes from an unspecified date in 1982. Patient previously took first dose of BNT162B2 (at the age of 71-year-old) (lot number: EN6203, vaccine location: Right arm) on 21Mar2021 for covid-19 immunisation and experienced a little tired on the same day and was also recovered on the same day. Consumer reported that she did not have any side effects until 3 days after she received the second dose of the Covid-19 vaccine. Consumer did not provide details for past medications. On 14Apr2021, the patient experienced hip and joint pain, pain in arm and also mentioned that she felt hard to walk. It was also reported that the patient also experienced hard to sleep and mentioned pain in arm moved a little to the left arm on an unspecified date. Where the patient received treatment hard to sleep. The therapeutic measures were pain medicine before she goes to bed. It was reported that no additional vaccines administered. Patient did not visited emergency room and physician office regarding the event. Patient had no adverse events prior to vaccination. It was also mentioned that there was no family medical history relevant to events. Patient did not receive any other vaccines within 4 weeks to the COVID vaccine. The patient underwent lab tests and procedures which included anion gap resulted 2.7 (unspecified units), blood chloride resulted 108 (unspecified units), blood thyroid stimulating hormone resulted low, bone densitometry resulted osteoporosis went down, full blood count resulted normal, lipids resulted 81 (unspecified units), mammogram resulted normal, thyroxin binding globulin resulted 1.0 (unspecified units), thyroxine: 0.87 (unspecified units) and ultrasound breast and normal all on 08Apr2021. Outcome of hard to sleep was unknown. Outcome of all the other events was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Thyroxin binding globulin, Thyroxine, Ultrasound breast
Clinical narrative: Hip and joint pain; Pain in arm; Hard to walk; Pain in arm moved a little to the left arm; hard to sleep; This is a spontaneous report from a contactable consumer (patient). A 71-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 2 via an unspecified route of administration, administered in right arm on 11Apr2021 at 15:15 (at the age of 71-year-old) (Batch/Lot Number: ER8730) as dose 2, single for covid-19 immunisation. Medical history included ongoing sleep apnoea, ongoing hypothyroidism, ongoing Hashimoto's disease, osteopenia, ongoing dry eye, ongoing depression, ongoing weight adjustment, ongoing selenium all from an unspecified date where patient states that need selenium and don't get enough in food. And also ongoing herpes from an unspecified date in 1982. Patient previously took first dose of BNT162B2 (at the age of 71-year-old) (lot number: EN6203, vaccine location: Right arm) on 21Mar2021 for covid-19 immunisation and experienced a little tired on the same day and was also recovered on the same day. Consumer reported that she did not have any side effects until 3 days after she received the second dose of the Covid-19 vaccine. Consumer did not provide details for past medications. On 14Apr2021, the patient experienced hip and joint pain, pain in arm and also mentioned that she felt hard to walk. It was also reported that the patient also experienced hard to sleep and mentioned pain in arm moved a little to the left arm on an unspecified date. Where the patient received treatment hard to sleep. The therapeutic measures were pain medicine before she goes to bed. It was reported that no additional vaccines administered. Patient did not visited emergency room and physician office regarding the event. Patient had no adverse events prior to vaccination. It was also mentioned that there was no family medical history relevant to events. Patient did not receive any other vaccines within 4 weeks to the COVID vaccine. The patient underwent lab tests and procedures which included anion gap resulted 2.7 (unspecified units), blood chloride resulted 108 (unspecified units), blood thyroid stimulating hormone resulted low, bone densitometry resulted osteoporosis went down, full blood count resulted normal, lipids resulted 81 (unspecified units), mammogram resulted normal, thyroxin binding globulin resulted 1.0 (unspecified units), thyroxine: 0.87 (unspecified units) and ultrasound breast and normal all on 08Apr2021. Outcome of hard to sleep was unknown. Outcome of all the other events was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Autoimmune disorder, Bone pain, Feeling abnormal, Hypoaesthesia
Clinical narrative: Developed knots all over hands week after getting 1st dose. Also developed 3 types of arthritis after vaccination, lots of blood work in past 5-6 months, have seen lots of doctors in past 5-6 months, in therapy of arthritis, tried to contact compensation program, with no help. Is now disabled after vaccine, and wasn't disabled at all before vaccine.  Patient did not provide lot number, he was too upset.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Illness, Laboratory test, Monoplegia, Nausea, Nodule
Clinical narrative: Developed knots all over hands week after getting 1st dose. Also developed 3 types of arthritis after vaccination, lots of blood work in past 5-6 months, have seen lots of doctors in past 5-6 months, in therapy of arthritis, tried to contact compensation program, with no help. Is now disabled after vaccine, and wasn't disabled at all before vaccine.  Patient did not provide lot number, he was too upset.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: Developed knots all over hands week after getting 1st dose. Also developed 3 types of arthritis after vaccination, lots of blood work in past 5-6 months, have seen lots of doctors in past 5-6 months, in therapy of arthritis, tried to contact compensation program, with no help. Is now disabled after vaccine, and wasn't disabled at all before vaccine.  Patient did not provide lot number, he was too upset.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthritis, Blood test, Disability, Magnetic resonance imaging, Nodule
Clinical narrative: Developed knots all over hands week after getting 1st dose. Also developed 3 types of arthritis after vaccination, lots of blood work in past 5-6 months, have seen lots of doctors in past 5-6 months, in therapy of arthritis, tried to contact compensation program, with no help. Is now disabled after vaccine, and wasn't disabled at all before vaccine.  Patient did not provide lot number, he was too upset.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: SIRVA, Shoulder Injury related to vaccine administrations.  Loss of range of motion, pain.  Completed physical therapy which did not help.  Am having MRI tomorrow to determine the type of injury ie bursitis, rotator cuff tear.  Pain started a few days after vaccine, and have continued.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Joint range of motion decreased, Shoulder injury related to vaccine administration, X-ray
Clinical narrative: SIRVA, Shoulder Injury related to vaccine administrations.  Loss of range of motion, pain.  Completed physical therapy which did not help.  Am having MRI tomorrow to determine the type of injury ie bursitis, rotator cuff tear.  Pain started a few days after vaccine, and have continued.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Fatigue, Pruritus, Rash erythematous, Rash papular
Clinical narrative: 4 days after vaccine, a rash developed on the inside of both forearms. Large red bumps, severe burning and itching. Rash spread from bend in elbow to wrists over the next 5 days. After 3 weeks, it began to clear. About a week later, I developed extreme fatigue, to the point of sleeping more than 12 hours a day, with fatigue and depression. (I am typically a very active person). Literally brought me to tears. Lasted about 3 weeks. That went away as suddenly as it came, and then I developed itching on the palm of my left had, with tingling and numbness from the wrist to the armpit. This still remains as of 11/2/2021. Numbness and tingling are 24 hours a day.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test, Somnolence
Clinical narrative: 4 days after vaccine, a rash developed on the inside of both forearms. Large red bumps, severe burning and itching. Rash spread from bend in elbow to wrists over the next 5 days. After 3 weeks, it began to clear. About a week later, I developed extreme fatigue, to the point of sleeping more than 12 hours a day, with fatigue and depression. (I am typically a very active person). Literally brought me to tears. Lasted about 3 weeks. That went away as suddenly as it came, and then I developed itching on the palm of my left had, with tingling and numbness from the wrist to the armpit. This still remains as of 11/2/2021. Numbness and tingling are 24 hours a day.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Depression, Fatigue, Hypersomnia, Hypoaesthesia
Clinical narrative: 4 days after vaccine, a rash developed on the inside of both forearms. Large red bumps, severe burning and itching. Rash spread from bend in elbow to wrists over the next 5 days. After 3 weeks, it began to clear. About a week later, I developed extreme fatigue, to the point of sleeping more than 12 hours a day, with fatigue and depression. (I am typically a very active person). Literally brought me to tears. Lasted about 3 weeks. That went away as suddenly as it came, and then I developed itching on the palm of my left had, with tingling and numbness from the wrist to the armpit. This still remains as of 11/2/2021. Numbness and tingling are 24 hours a day.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Pruritus, Rash, Rash erythematous
Clinical narrative: 4 days after vaccine, a rash developed on the inside of both forearms. Large red bumps, severe burning and itching. Rash spread from bend in elbow to wrists over the next 5 days. After 3 weeks, it began to clear. About a week later, I developed extreme fatigue, to the point of sleeping more than 12 hours a day, with fatigue and depression. (I am typically a very active person). Literally brought me to tears. Lasted about 3 weeks. That went away as suddenly as it came, and then I developed itching on the palm of my left had, with tingling and numbness from the wrist to the armpit. This still remains as of 11/2/2021. Numbness and tingling are 24 hours a day.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Herpes zoster oticus, Nausea, Photophobia
Clinical narrative: Nausea/vomiting/headaches - August 26, 2021 starting at 7am Intense headaches, visual problems, eye pain, Bells Palsy, scalp pain starting September 1, 2021 - continuing until November 1, 2021
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bell's palsy, Eye pain, Headache, Nausea, Pain of skin
Clinical narrative: Nausea/vomiting/headaches - August 26, 2021 starting at 7am Intense headaches, visual problems, eye pain, Bells Palsy, scalp pain starting September 1, 2021 - continuing until November 1, 2021
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Visual impairment, Vomiting
Clinical narrative: Nausea/vomiting/headaches - August 26, 2021 starting at 7am Intense headaches, visual problems, eye pain, Bells Palsy, scalp pain starting September 1, 2021 - continuing until November 1, 2021
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood pressure decreased, Dizziness, Eye inflammation, Eye pain, Fatigue
Clinical narrative: legs scanned for blood clots; Terrible headaches; Asthma; Blurred vision; This is a spontaneous report from a contactable consumer (patient) forwarded as an Adverse Event. A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date, dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered via an unspecified route of administration on an unspecified date, dose 1, single for COVID-19 immunisation. On an unspecified date, the patient took the shot 2, months ago. The patient had been to neurologists for terrible headaches. A pulmonary doctor told the patient that the patient had asthma, and the legs were scanned for blood clots. The patient had magnetic resonance imaging (MRI) for chest and visited wellness clinics. It was stated the patient had missed works because having blurred vision and stated all these terrible side effects from one shot. The patient suffered terrible side effects to the day of report. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fear, Feeling abnormal, Gait disturbance, Head discomfort, Laboratory test
Clinical narrative: legs scanned for blood clots; Terrible headaches; Asthma; Blurred vision; This is a spontaneous report from a contactable consumer (patient) forwarded as an Adverse Event. A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date, dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered via an unspecified route of administration on an unspecified date, dose 1, single for COVID-19 immunisation. On an unspecified date, the patient took the shot 2, months ago. The patient had been to neurologists for terrible headaches. A pulmonary doctor told the patient that the patient had asthma, and the legs were scanned for blood clots. The patient had magnetic resonance imaging (MRI) for chest and visited wellness clinics. It was stated the patient had missed works because having blurred vision and stated all these terrible side effects from one shot. The patient suffered terrible side effects to the day of report. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Loss of consciousness, Magnetic resonance imaging, Muscular weakness, Ocular discomfort, Pain
Clinical narrative: legs scanned for blood clots; Terrible headaches; Asthma; Blurred vision; This is a spontaneous report from a contactable consumer (patient) forwarded as an Adverse Event. A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date, dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered via an unspecified route of administration on an unspecified date, dose 1, single for COVID-19 immunisation. On an unspecified date, the patient took the shot 2, months ago. The patient had been to neurologists for terrible headaches. A pulmonary doctor told the patient that the patient had asthma, and the legs were scanned for blood clots. The patient had magnetic resonance imaging (MRI) for chest and visited wellness clinics. It was stated the patient had missed works because having blurred vision and stated all these terrible side effects from one shot. The patient suffered terrible side effects to the day of report. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Paraesthesia, Tilt table test positive
Clinical narrative: legs scanned for blood clots; Terrible headaches; Asthma; Blurred vision; This is a spontaneous report from a contactable consumer (patient) forwarded as an Adverse Event. A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date, dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered via an unspecified route of administration on an unspecified date, dose 1, single for COVID-19 immunisation. On an unspecified date, the patient took the shot 2, months ago. The patient had been to neurologists for terrible headaches. A pulmonary doctor told the patient that the patient had asthma, and the legs were scanned for blood clots. The patient had magnetic resonance imaging (MRI) for chest and visited wellness clinics. It was stated the patient had missed works because having blurred vision and stated all these terrible side effects from one shot. The patient suffered terrible side effects to the day of report. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Asthma, Blood pressure decreased, Blood pressure measurement, Coagulation time
Clinical narrative: legs scanned for blood clots; Terrible headaches; Asthma; Blurred vision; This is a spontaneous report from a contactable consumer (patient) forwarded as an Adverse Event. A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date, dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered via an unspecified route of administration on an unspecified date, dose 1, single for COVID-19 immunisation. On an unspecified date, the patient took the shot 2, months ago. The patient had been to neurologists for terrible headaches. A pulmonary doctor told the patient that the patient had asthma, and the legs were scanned for blood clots. The patient had magnetic resonance imaging (MRI) for chest and visited wellness clinics. It was stated the patient had missed works because having blurred vision and stated all these terrible side effects from one shot. The patient suffered terrible side effects to the day of report. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Disturbance in attention, Dizziness, Dysmenorrhoea, Dyspnoea, Eye disorder
Clinical narrative: legs scanned for blood clots; Terrible headaches; Asthma; Blurred vision; This is a spontaneous report from a contactable consumer (patient) forwarded as an Adverse Event. A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date, dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered via an unspecified route of administration on an unspecified date, dose 1, single for COVID-19 immunisation. On an unspecified date, the patient took the shot 2, months ago. The patient had been to neurologists for terrible headaches. A pulmonary doctor told the patient that the patient had asthma, and the legs were scanned for blood clots. The patient had magnetic resonance imaging (MRI) for chest and visited wellness clinics. It was stated the patient had missed works because having blurred vision and stated all these terrible side effects from one shot. The patient suffered terrible side effects to the day of report. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Eye inflammation, Eye pain, Feeling abnormal, Gait disturbance, Head discomfort
Clinical narrative: legs scanned for blood clots; Terrible headaches; Asthma; Blurred vision; This is a spontaneous report from a contactable consumer (patient) forwarded as an Adverse Event. A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date, dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered via an unspecified route of administration on an unspecified date, dose 1, single for COVID-19 immunisation. On an unspecified date, the patient took the shot 2, months ago. The patient had been to neurologists for terrible headaches. A pulmonary doctor told the patient that the patient had asthma, and the legs were scanned for blood clots. The patient had magnetic resonance imaging (MRI) for chest and visited wellness clinics. It was stated the patient had missed works because having blurred vision and stated all these terrible side effects from one shot. The patient suffered terrible side effects to the day of report. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Impaired work ability, Loss of consciousness, Lung disorder, Magnetic resonance imaging
Clinical narrative: legs scanned for blood clots; Terrible headaches; Asthma; Blurred vision; This is a spontaneous report from a contactable consumer (patient) forwarded as an Adverse Event. A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date, dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered via an unspecified route of administration on an unspecified date, dose 1, single for COVID-19 immunisation. On an unspecified date, the patient took the shot 2, months ago. The patient had been to neurologists for terrible headaches. A pulmonary doctor told the patient that the patient had asthma, and the legs were scanned for blood clots. The patient had magnetic resonance imaging (MRI) for chest and visited wellness clinics. It was stated the patient had missed works because having blurred vision and stated all these terrible side effects from one shot. The patient suffered terrible side effects to the day of report. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Menstruation irregular, Nervous system disorder, Oxygen saturation, Paraesthesia
Clinical narrative: legs scanned for blood clots; Terrible headaches; Asthma; Blurred vision; This is a spontaneous report from a contactable consumer (patient) forwarded as an Adverse Event. A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date, dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered via an unspecified route of administration on an unspecified date, dose 1, single for COVID-19 immunisation. On an unspecified date, the patient took the shot 2, months ago. The patient had been to neurologists for terrible headaches. A pulmonary doctor told the patient that the patient had asthma, and the legs were scanned for blood clots. The patient had magnetic resonance imaging (MRI) for chest and visited wellness clinics. It was stated the patient had missed works because having blurred vision and stated all these terrible side effects from one shot. The patient suffered terrible side effects to the day of report. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthma, Headache, Magnetic resonance imaging, Scan, Thrombosis
Clinical narrative: legs scanned for blood clots; Terrible headaches; Asthma; Blurred vision; This is a spontaneous report from a contactable consumer (patient) forwarded as an Adverse Event. A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date, dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered via an unspecified route of administration on an unspecified date, dose 1, single for COVID-19 immunisation. On an unspecified date, the patient took the shot 2, months ago. The patient had been to neurologists for terrible headaches. A pulmonary doctor told the patient that the patient had asthma, and the legs were scanned for blood clots. The patient had magnetic resonance imaging (MRI) for chest and visited wellness clinics. It was stated the patient had missed works because having blurred vision and stated all these terrible side effects from one shot. The patient suffered terrible side effects to the day of report. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vision blurred
Clinical narrative: legs scanned for blood clots; Terrible headaches; Asthma; Blurred vision; This is a spontaneous report from a contactable consumer (patient) forwarded as an Adverse Event. A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date, dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered via an unspecified route of administration on an unspecified date, dose 1, single for COVID-19 immunisation. On an unspecified date, the patient took the shot 2, months ago. The patient had been to neurologists for terrible headaches. A pulmonary doctor told the patient that the patient had asthma, and the legs were scanned for blood clots. The patient had magnetic resonance imaging (MRI) for chest and visited wellness clinics. It was stated the patient had missed works because having blurred vision and stated all these terrible side effects from one shot. The patient suffered terrible side effects to the day of report. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Fatigue, Laryngitis, Lymphadenopathy, Nasal congestion
Clinical narrative: Swollen lymph nodes at different locations: under arm, bra line, throat; Sore throat; Fatigue; Some depression; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0191) via an unspecified route of administration in the left arm on 13Sep2021 at 14:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and COVID-19. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID) from an unknown date for an unknown indication and unknown if ongoing. On 14Sep2021, the patient experienced sore throat, fatigue, some depression and swollen lymph nodes at different locations; under arm, bra line, throat. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore throat, fatigue, some depression and swollen lymph nodes at different locations; under arm, bra line, throat was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal pain, Pruritus, Rash, Rash vesicular, SARS-CoV-2 test negative
Clinical narrative: Swollen lymph nodes at different locations: under arm, bra line, throat; Sore throat; Fatigue; Some depression; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0191) via an unspecified route of administration in the left arm on 13Sep2021 at 14:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and COVID-19. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID) from an unknown date for an unknown indication and unknown if ongoing. On 14Sep2021, the patient experienced sore throat, fatigue, some depression and swollen lymph nodes at different locations; under arm, bra line, throat. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore throat, fatigue, some depression and swollen lymph nodes at different locations; under arm, bra line, throat was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Scab
Clinical narrative: Swollen lymph nodes at different locations: under arm, bra line, throat; Sore throat; Fatigue; Some depression; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0191) via an unspecified route of administration in the left arm on 13Sep2021 at 14:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and COVID-19. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID) from an unknown date for an unknown indication and unknown if ongoing. On 14Sep2021, the patient experienced sore throat, fatigue, some depression and swollen lymph nodes at different locations; under arm, bra line, throat. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore throat, fatigue, some depression and swollen lymph nodes at different locations; under arm, bra line, throat was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Depression, Fatigue, Lymphadenopathy, Oropharyngeal pain
Clinical narrative: Swollen lymph nodes at different locations: under arm, bra line, throat; Sore throat; Fatigue; Some depression; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0191) via an unspecified route of administration in the left arm on 13Sep2021 at 14:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and COVID-19. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID) from an unknown date for an unknown indication and unknown if ongoing. On 14Sep2021, the patient experienced sore throat, fatigue, some depression and swollen lymph nodes at different locations; under arm, bra line, throat. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore throat, fatigue, some depression and swollen lymph nodes at different locations; under arm, bra line, throat was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Deep vein thrombosis, Ultrasound Doppler abnormal
Clinical narrative: 1 week after vaccine patient reports he started to have a dull pain in his right leg. On 10/3/21 he was seen in the ED at Hospital where he was diagnosed with a DVT of right popliteal and right posterior tibial veins. He was started on apixaban 10mg bid x 7 days then 5mg bid for DVT treatment.  On 10/11/21 he presented to the ED at the hospital with complaints of dyspnea and was diagnosed with acute bilateral pulmonary embolism. Denies any family history of blood clots.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Computerised tomogram thorax abnormal, Deep vein thrombosis, Dyspnoea, Pain in extremity
Clinical narrative: 1 week after vaccine patient reports he started to have a dull pain in his right leg. On 10/3/21 he was seen in the ED at Hospital where he was diagnosed with a DVT of right popliteal and right posterior tibial veins. He was started on apixaban 10mg bid x 7 days then 5mg bid for DVT treatment.  On 10/11/21 he presented to the ED at the hospital with complaints of dyspnea and was diagnosed with acute bilateral pulmonary embolism. Denies any family history of blood clots.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulmonary embolism, Ultrasound Doppler abnormal
Clinical narrative: 1 week after vaccine patient reports he started to have a dull pain in his right leg. On 10/3/21 he was seen in the ED at Hospital where he was diagnosed with a DVT of right popliteal and right posterior tibial veins. He was started on apixaban 10mg bid x 7 days then 5mg bid for DVT treatment.  On 10/11/21 he presented to the ED at the hospital with complaints of dyspnea and was diagnosed with acute bilateral pulmonary embolism. Denies any family history of blood clots.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dysgeusia, Headache, Injection site pain, Nausea
Clinical narrative: Headache; Nausea; Metallic taste; Pain at injection site; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on an unknown date (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to penicillin and sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 07Oct2021 at 14:30, the patient had headache, nausea, metallic taste and pain at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, nausea, metallic taste and pain at injection site was not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.